Novartis NVS has entered into a global license and collaboration agreement with PTC Therapeutics PTCT for the latter’s ...

US biopharma Olema Pharmaceuticals has announced a clinical trial collaboration and supply agreement with Swiss pharma giant ...

J.P. Morgan analyst Anupam Rama has maintained their bullish stance on OLMA stock, giving a Buy rating on November 26.Don't Miss our Black ...

Olema Pharmaceuticals prepares for its OPERA-02 study, targeting ER+/HER2- breast cancer. Read why OLMA stock could benefit ...

EST Olema Oncology (OLMA) up 13% at $11.40 after entering supply pact with NovartisDon't Miss our Black Friday Offers:Unlock your ...

Short OLMA slightly under 9.33, target n/a, stop loss @ 9.36 Check the time stamp on this data. Updated AI-Generated Signals ...

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Equities research analysts at HC Wainwright decreased their FY2024 earnings per share estimates for shares of Olema Pharmaceuticals in ...

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report)’s share price gapped up prior to trading on Friday .The stock had previously closed at $7.87, but opened at $8.21. Olema ...

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...